(NU/1338) The Supply of Automated Radiochemistry Synthesis Platforms
Newcastle Universitygoods
What the buyer wrote
The radiochemistry platforms sought, will support ongoing Neuroscience research by facilitating GMPproduction of markers of abnormal protein aggregation (e.g. amyloid, tau, and alpha synuclein) in order to studyin vivo, the pathology of Dementias (Lewy body, Parkinson's Disease, Alzheimer's Disease) and provide proofof mechanism of interventions designed to reverse or remove abnormal oligomers and fibrils - immunotherapy,secretase blockers, anti-aggregants, etc.The tendered platforms will also provide workhorse imaging biomarkers to detect tumours and monitor their function
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- (NU/1338) The Supply of Automated Radiochemistry Synthesis Platforms
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 30 Sep 2018
- Work ends
- 6 Dec 2021
Who the buyer named
Dave Anderson was the named contact on this notice.